InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Gayer Charles K, Directeur Commercial. Director active across 1 company, notably Biocryst Pharmaceuticals INC. Cumulatively, 16 disclosures have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €214k. Activity tracked since 14 December 2021. The latest transaction was disclosed on 19 December 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gayer Charles K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
11,477 股@ US$7.4110.4% 占其流量Common StockSEC:0000882796-25-000041:0
14,142 股@ US$3.225.6% 占其流量Common StockSEC:0000882796-25-000041:1
10,091 股@ US$5.046.2% 占其流量Common StockSEC:0000882796-25-000041:2
50,000 股@ US$5.5133.9% 占其流量Common StockSEC:0000882796-25-000041:3
471,000 股0Common StockSEC:0001171843-25-008038:0
8,181 股@ US$7.577.1% 占其流量Common StockSEC:0000882796-25-000036:0
2,461 股@ US$7.392.5% 占其流量Common StockSEC:0001127602-24-029971:1
125,950 股0Common StockSEC:0001127602-24-029971:0
8,251 股@ US$7.538.5% 占其流量Common StockSEC:0001127602-24-029602:0
30,000 股@ US$5.4721.9% 占其流量Common StockSEC:0001127602-24-015363:0
标准退出：2024年8月11日 (T+90)
2,482 股@ US$6.052.0% 占其流量Common StockSEC:0001127602-23-030185:0
34,000 股0Common StockSEC:0001127602-23-029833:0
34,000 股0Common StockSEC:0001127602-22-028076:0
6,100 股@ US$10.909.0% 占其流量Common StockSEC:0001127602-22-027875:0
80,000 股0Common StockSEC:0001127602-22-001454:0
125,000 股0Common StockSEC:0001127602-21-031137:0
16 条申报中的 16 条
About Gayer Charles K
Gayer Charles K is Directeur Commercial and President and CCO at Biocryst Pharmaceuticals INC. He has 16 filings in total, and across the sampled recent filings the buys amount to EUR 152035 and the sells to EUR 62278, spanning from 2021-12-16 to 2025-12-23, with the modal transaction nature shown as Attribution.
